Table 1.
Clinical factors | Categories | Summary measure |
---|---|---|
Age | < 55 years | 1 (3.0%) |
[mean, 75.6 years; 41-98 years] | 55 ≤, < 65 years | 4 (12.1%) |
65 ≤, < 75 years | 8 (24.2%) | |
75 ≤, < 85 years | 15 (45.5%) | |
85 years ≤ | 5 (15.2%) | |
Sex | Male | 19 (57.6%) |
Female | 14 (42.4%) | |
Samples (35 samples) | arterial blood | 6 (18.2%) |
venous blood | 19 (57.6%) | |
bile | 6 (18.2%) | |
peritoneal fluid | 3 (9.1%) | |
surgical wound (pus) | 1 (3.0%) | |
Clinical Diagnosis | cholangitis/cholecystitis | 6 (18.2%) |
urinary tract infection | 5 (15.2%) | |
peritonitis | 5 (15.2%) | |
pneumonia | 5 (15.2%) | |
sepsis | 4 (12.1%) | |
liver abscess | 2 (6.1%) | |
enterocolitis | 2 (6.1%) | |
infectious endocarditis | 1 (3.0%) | |
surgical site infection | 1 (3.0%) | |
myonecrosis | 1 (3.0%) | |
unknown | 1 (3.0%) | |
Entry site | respiratory tract | 5 (15.2%) |
urinary tract | 5 (15.2%) | |
bowel | 6 (18.2%) | |
biliary tract | 8 (24.2%) | |
surgical wound | 1 (3.0%) | |
unknown | 8 (24.2%) | |
Clinical condition | Sepsis (*SIRS) | 21 (63.6%) |
Bacteremia (without SIRS) | 7 (21.2%) | |
Others | 5 (15.2%) | |
Trigger | operation or intervention | 15 (45.5%) |
cancer | 9 (27.3%) | |
non-neoplastic disease | 6 (18.2%) | |
Immunocompromised factor | diabetes | 4 (12.1%) |
liver cirrhosis | 3 (9.1%) | |
chemo (radiation) therapy | 2 (6.1%) | |
interstitial pneumonia | 2 (6.1%) | |
hemodialysis | 2 (6.1%) |
SIRS, systemic inflammatory response syndrome.